Literature DB >> 21621023

From in silico target prediction to multi-target drug design: current databases, methods and applications.

Alexios Koutsoukas1, Benjamin Simms, Johannes Kirchmair, Peter J Bond, Alan V Whitmore, Steven Zimmer, Malcolm P Young, Jeremy L Jenkins, Meir Glick, Robert C Glen, Andreas Bender.   

Abstract

Given the tremendous growth of bioactivity databases, the use of computational tools to predict protein targets of small molecules has been gaining importance in recent years. Applications span a wide range, from the 'designed polypharmacology' of compounds to mode-of-action analysis. In this review, we firstly survey databases that can be used for ligand-based target prediction and which have grown tremendously in size in the past. We furthermore outline methods for target prediction that exist, both based on the knowledge of bioactivities from the ligand side and methods that can be applied in situations when a protein structure is known. Applications of successful in silico target identification attempts are discussed in detail, which were based partly or in whole on computational target predictions in the first instance. This includes the authors' own experience using target prediction tools, in this case considering phenotypic antibacterial screens and the analysis of high-throughput screening data. Finally, we will conclude with the prospective application of databases to not only predict, retrospectively, the protein targets of a small molecule, but also how to design ligands with desired polypharmacology in a prospective manner.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 21621023     DOI: 10.1016/j.jprot.2011.05.011

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  70 in total

1.  Drug search for leishmaniasis: a virtual screening approach by grid computing.

Authors:  Rodrigo Ochoa; Stanley J Watowich; Andrés Flórez; Carol V Mesa; Sara M Robledo; Carlos Muskus
Journal:  J Comput Aided Mol Des       Date:  2016-07-20       Impact factor: 3.686

2.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

Review 3.  Diverse array-designed modes of combination therapies in Fangjiomics.

Authors:  Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

Review 4.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

5.  Cluster Analysis of Medicinal Plants and Targets Based on Multipartite Network.

Authors:  Namgil Lee; Hojin Yoo; Heejung Yang
Journal:  Biomolecules       Date:  2021-04-08

6.  How promiscuous are pharmaceutically relevant compounds? A data-driven assessment.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2012-10-23       Impact factor: 4.009

Review 7.  Shifting from the single to the multitarget paradigm in drug discovery.

Authors:  José L Medina-Franco; Marc A Giulianotti; Gregory S Welmaker; Richard A Houghten
Journal:  Drug Discov Today       Date:  2013-01-20       Impact factor: 7.851

8.  Novel synthetic biscoumarins target tumor necrosis factor-α in hepatocellular carcinoma in vitro and in vivo.

Authors:  Hosadurga Kumar Keerthy; Chakrabhavi Dhananjaya Mohan; Kodappully Sivaraman Siveen; Julian E Fuchs; Shobith Rangappa; Mahalingam S Sundaram; Feng Li; Kesturu S Girish; Gautam Sethi; Andreas Bender; Kanchugarakoppal Subbegowda Rangappa
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 9.  Target deconvolution techniques in modern phenotypic profiling.

Authors:  Jiyoun Lee; Matthew Bogyo
Journal:  Curr Opin Chem Biol       Date:  2013-01-18       Impact factor: 8.822

Review 10.  Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics.

Authors:  Patrick M McNeely; Andrea N Naranjo; Anne S Robinson
Journal:  Biotechnol J       Date:  2012-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.